BackX4 Pharmaceuticals Overview

X4 Pharmaceuticals Total Revenue

Revenue analysis for XFOR.

Quarterly Revenue

$2.71M
↓ 90.6% YoY

As of Mar 2026

Annual Revenue (TTM)

$9.01M
↓ 71.26% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin